Menveo

Chasing Pfizer, GSK's 5-in-1 meningococcal vaccine delivers phase 3 trial win
Chasing Pfizer, GSK's 5-in-1 meningococcal vaccine delivers phase 3 trial win
Fierce Pharma
vaccines
GSK
Pfizer
meningococcal disease
Menveo
Bexsero
Flag link:
FDA approves single-vial version of GSK's Menveo vaccine, ending need for reconstitution
FDA approves single-vial version of GSK's Menveo vaccine, ending need for reconstitution
Fierce Pharma
GSK
FDA
vaccines
Menveo
meningococcal disease
Flag link:
Are Glaxo's Successful New Drugs Enough to Drive Growth?
Are Glaxo's Successful New Drugs Enough to Drive Growth?
Yahoo/Zacks.com
GSK
Triumeq
Tivicay
Anoro
Incruse
Menveo
Bexsero
Shingrix
Nucala
Flag link:
Sanofi's meningococcal vax rivalry with Novartis ends in $61.5M class-action settlement
Sanofi's meningococcal vax rivalry with Novartis ends in $61.5M class-action settlement
Fierce Pharma
Sanofi
meningococcal disease
Novartis
vaccines
Menveo
Menactra
Flag link:
GlaxoSmithKline Giving a Shot to Its Vaccines Business
GlaxoSmithKline Giving a Shot to Its Vaccines Business
Market Realist
GSK
vaccines
Novartis
M&A
Rotarix
Boostrix
Bexsero
Menveo
Flag link:
Who Would Have Ever Thought A Vaccine To Protect Babies' Brains Could Be A Tough Sell?
Who Would Have Ever Thought A Vaccine To Protect Babies' Brains Could Be A Tough Sell?
Forbes
vaccines
Novartis
Menveo
Bexsero
meningococcal disease
Flag link:
U.S. delays decision on Novartis's meningitis drug
U.S. delays decision on Novartis's meningitis drug
Reuters
Novartis
meningitis
Menveo
FDA
Flag link:
Sanofi Accused Of Anticompetitive Vaccine Pricing
Sanofi Accused Of Anticompetitive Vaccine Pricing
Pharmalot
Sanofi
vaccines
drug pricing
Novartis
Menveo
Menactra
Flag link:
Novartis Vaccine for FDA Review
Novartis Vaccine for FDA Review
Yahoo/Zacks
Novartis
Menveo
meningitis
Flag link:
Novartis Says FDA Approves Menveo in Kids, Not Infants
Novartis Says FDA Approves Menveo in Kids, Not Infants
Bloomberg
FDA
Novartis
vaccines
Menveo
meningococcal disease
Flag link:
Novartis trial of meningococcal vaccine meets goal
Novartis trial of meningococcal vaccine meets goal
Marketwatch
Novartis
vaccines
Menveo
meningococcal disease
Flag link:
FDA Accepts Novartis Vaccines' sBLA to Expand Indication of Menveo(R) to Children 2-10 Years of Age
FDA Accepts Novartis Vaccines' sBLA to Expand Indication of Menveo(R) to Children 2-10 Years of Age
Yahoo/MarketWire
Novartis
bacterial meningitis
Menveo
Flag link:
NVS Drug to boost Vaccines Segment
NVS Drug to boost Vaccines Segment
Yahoo/Zacks.com
Novartis
vaccines
Menveo
Flag link:
Novartis gets FDA approval for Menveo
Novartis gets FDA approval for Menveo
Marketwatch
FDA
vaccines
Novartis
Menveo
Flag link: